openPR Logo
Press release

CD Bioparticles Releases Chitosans for Research Use

02-25-2021 09:32 AM CET | Science & Education

Press release from: CD Bioparticles

As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies. These new chitosans and derivatives are with various water solubility, and scientists now are accessible to products like CInd™ analogous hyaluronic acid chitosan, CInd™ carboxymethyl chitosan, CInd™ chitosan azelate and glycol chitin.

One new product in this new release is the CInd™ Chitosan Azelate, which is water soluble, and the solution is neutral, clear and stable. Chitosan Azelate can be used in speckle-removing skin care cosmetic, which has the role of Azelate of bacteriostasis, elimination of melanin and acne; it also has the function of chitosan of biocompatibility and filming, which can inhibit the bacteria, mold, and melanin synthesis enzyme activity. Compared to the other speckle-removing skin care cosmetic, the advantage of this product is that it is effective with higher levels of azelaic acid, which can be achieved 4% of the total weight; it also has other advantages such as speckle-removing, anti acne, whitening, moisturizing and antiwrinkle. It is used as cosmetics or cosmetic raw materials, without side effects.

Another example is CInd™ Chitosan Lactate, which is off-white or yellowish powder. Chitosan lactate with a better biocompatibility has excellent functions of antibacterial activity, moisture retention, preventing disease, keeping healthy and other special purposes. It is widely used in the fields like dressing, hygienic materials, biochemistry, health foods, functional food, food additives, and intermediates. Chitosan lactate is made from natural raw materials, without touching the other chemical raw materials in the production process, therefore it is more natural and safe.

CD Bioparticles offers biopolymers & synthetic polymers for assisting customers' drug delivery research programs, and this new series of chitosans, together with its customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms can help researchers to solve different drug delivery challenges during the study. "Our chitosan products are organized by functional groups, namely N/A, biotin, hydroxyl, and thiol. You can easily find each of our chitosan polymers and inquiry about these new products." said Dr. Robin J. Watts, the product portfolio manager of CD Bioparticles.

For more detailed information on chitosans or biopolymers & synthetic polymers, please contact CD Bioparticles or visit its website directly at https://www.cd-bioparticles.net/.

CD Bioparticles
Shirley, NY 11967, USA

About CD Bioparticles

CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD Bioparticles Releases Chitosans for Research Use here

News-ID: 2248511 • Views:

More Releases from CD Bioparticles

CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents. CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such
CD Bioparticles Announces New Protein Magnetic Particles for Bio-application
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a series of protein magnetic particles that can be applied for a variety of research applications such as immunocapture, biopanning and flow cytometry. These new product are an addition of CD Bioparticles' affinity magnetic particles portfolio. Affinity magnetic particles can be used for affinity purification and separation of antibodies, antigens, proteins and DNA/RNA. These particles have
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings. With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the
CD Bioparticles Releases New Block Copolymer Micelles for Drug Delivery Research
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of block copolymer micelles for global researchers to help solve the challenges faced in the studies such as limited drug-loading efficiency and yield, unpredictable or uncontrollable degradation rate of the drug-loading cargo, or uncontrollable drug delivery profile. These newly released products are applicable for a variety of potential usages, like biocompatible and

All 5 Releases


More Releases for CInd™

Phase-out of 3M™ Novec™ Engineered Fluids
In December 2022, 3M™ announced their plans to stop producing per- and polyfluoroalkyl substances (PFAS) in its product line. Final order dates have now been set for March 31st 2025, and the supply of these products will end on December 31st 2025. This phase-out affects the following 3M™ product lines: 3M™ Novec™ Engineered Fluids 3M™ Fluorinert™ Electronic Liquids With 3M™ discontinuing these products, many companies are now evaluating alternatives to find suitable replacements.
MetaFix™ PlantarMAX™ Foot Plate received FDA-Release
Merete Medical GmbH announces the FDA-approval for MetaFix™ PlantarMAX™ plate. PlantarMAX™ is designed as the first plantar/medial Lapidus fixation plate which takes advantage of the biomechanically superior fixation on the tension side of the Metatarsal/Cuneiform joint during a Lapidus Hallux Valgus correction procedure. The fixation on the tension side of the joint is superior to dorsal or medial fixation and offers additional compression as the patient proceeds to weight bearing. Merete
Dali Wireless™ Introduces its Low Power t-Series Solution: tHost™ and t30™
Palo Alto, October 25, 2012 – Dali Wireless, a leader in next generation wireless infrastructure, today announced the release of its low power t-Series solution, which consists of the t30 remote unit and the tHost head-end. The exponential growth of mobile data capacity is challenging traditional cellular networks. Dali Wireless has created a unique solution to address these capacity limitations by combining industry standard protocols with the culmination of over
GFI™ Software Announces GFI LANguard™ 2011
Clearwater, FL – May 23, 2011 – GFI Software’s Infrastructure Business Unit today announced the launch of GFI LANguard™2011, the latest version of the company’s comprehensive network vulnerability scanning and patch management solution. GFI LANguard 2011 is the first network vulnerability and patch management solution to integrate with more than 1,500 security applications and to include keyword search functionality, illustrating GFI’s commitment to providing small and medium-sized businesses (SMBs) with
Pixelmetrix to launch Consolidator™, its new generation Network Management Sys …
Singapore – April 1, 2011 – Pixelmetrix, the global expert in Preventive Monitoring for digital television and IPTV networks, is set to launch Consolidator™, its new generation Network Management System, StationView™ for Simple, Effective Monitoring and the Electronic Couch Potato™ (ECP) Video Quality Index™ (VQI) for video quality verification. Consolidator™ provides centralized access and visibility of key network fault and performance information. Scalable to thousands of probes and millions of
SaferWatch™ announces TIN Manager™
HEBRON, ND – SaferWatch announces the release of their latest software solution, TIN Manager™. The TIN Manager feature is designed to verify the accuracy of Taxpayer Identification Number (TIN) and name information prior to submitting 1099’s to the IRS so that the company will not be penalized or fined for mismatches. TIN Manager eliminates tax preparation hassles by giving the bookkeeping departments of broker and shipper businesses a